The Next Round of Health Care Reform: Texas, the United States, and the World
Dell Medical School
The opportunities to have health care that is both affordable and innovative—that improves and lengthens lives—are better than ever. But to achieve that, we need to change our health care policies.
Friday, April 14, 2017 - 11:30AM - 1:00PM
AT&T Executive Education and Conference Center 1900 University Avenue Austin, TX 78712
Parking is available at the AT&T Executive Education and Conference Center parking garage and surrounding public lots.
Mark B. McClellan, MD, Ph.D., is a doctor and an economist whose work has addressed a wide range of strategies and policy reforms to improve health care, including payment reforms to promote better outcomes and lower costs, methods for development and use of real-world evidence, and approaches for more effective drug and device innovation.
In his presentation, Dr. McClellan will discuss national health care policy issues and the impact they have on health and businesses in Texas. He will review Texas's current health care policies in relation to the U.S. and world health care policies, including:
- Medicaid reform with regional innovation and transformation,
- drug pricing reforms,
- improving health care delivery,
- improving value and value-based payment reforms,
- next steps for health care leaders in Texas.
Dr. Mark McClellan, is Senior Health Policy Advisor for the Dell Medical School at The University of Texas at Austin. McClellan, the former head of the U.S. Food and Drug Administration and Centers for Medicare and Medicaid Services, works on health policy reform initiatives with colleagues at the medical school and across the UT campus.
Also serving as director of the Robert J. Margolis Center for Health Policy at Duke University, McClellan leads a collaboration between Duke and UT Austin, building on the strengths and population health interests of both institutions.
At the federal level, McClellan oversaw the development of the federal Medicare prescription drug benefit, the FDA’s Critical Path Initiative, and public-private initiatives focused on reforms creating value in health and health care. Most recently, he was a senior fellow and director of the Health Care Innovation and Value Initiatives at the Brookings Institution. McClellan grew up in Austin and graduated from the Plan II Honors program at UT Austin.
He previously served as a member of the President’s Council of Economic Advisers and as senior director for health care policy at the White House, and he was an associate professor of economics and medicine at Stanford University. He earned an M.D. from the Harvard University–Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, a Ph.D. in economics from MIT, and an M.P.A. from Harvard University. He is board-certified in internal medicine and has been a practicing internist during his career.